tiprankstipranks
Poseida Therapeutics, Inc. (PSTX)
NASDAQ:PSTX
US Market

Poseida Therapeutics (PSTX) Financial Statements

Compare
495 Followers

Poseida Therapeutics Financial Overview

Poseida Therapeutics's market cap is currently $925.92M. The company's EPS TTM is $-0.633; its P/E ratio is ―; Poseida Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 64.70M$ 130.49M$ 31.24M--
Operating Income$ -129.50M$ -59.95M$ -141.41M$ -126.55M$ -78.85M
EBITDA$ -109.04M$ -51.92M$ -117.06M$ -123.68M$ -81.78M
Net Income$ -123.43M$ -64.00M$ -124.97M$ -129.78M$ -86.53M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 273.88M$ 351.84M$ 269.31M$ 371.48M$ 147.00M
Total Debt$ 85.42M$ 88.75M$ 61.20M$ 59.31M$ 29.14M
Net Debt$ -126.78M$ -193.74M$ -145.13M$ -249.84M$ -96.18M
Total Liabilities$ 170.18M$ 164.24M$ 113.10M$ 109.52M$ 296.51M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -95.27M$ -30.71M$ -105.12M$ -130.21M$ -69.67M
Operating Cash Flow$ -92.17M$ -26.77M$ -102.50M$ -113.30M$ -64.52M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Poseida Therapeutics Earnings and Revenue History

Poseida Therapeutics Debt to Assets

Poseida Therapeutics Cash Flow

Poseida Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis